Target intelligence / Profile preview

POTEH antisense RNA 1 (POTEH-AS1)

Target
POTEH-AS1
Molecular classification
Long noncoding RNA (lncRNA), Natural antisense transcript, Other
01

Overview

POTEH antisense RNA 1 (POTEH-AS1) is a long noncoding RNA, specifically classified as a natural antisense transcript. Antisense RNAs such as POTEH-AS1 are transcribed from the DNA strand opposite to their corresponding sense gene and can regulate gene expression through various mechanisms. These mechanisms include blocking ribosome binding, recruiting RNase to degrade target mRNAs, or influencing chromatin and epigenetic states. While antisense lncRNAs have been identified as regulators in cancer and other diseases, there is currently no published biological function, disease association, or drug interaction reported for POTEH-AS1 itself in available scientific sources. Based on conventions, POTEH-AS1 is not considered a therapeutic target (e.g., receptor, enzyme, transporter) but rather a regulatory noncoding RNA. There is insufficient or missing information on its function, clinical relevance, or possible drug interactions, and no evidence that it serves as a disease biomarker or is involved in safety concerns. POTEH antisense RNA 1 (POTEH-AS1) appears to be a long noncoding RNA of the antisense class, involved in gene expression regulation. It is not a conventional therapeutic target, has no known aliases beyond its full name and abbreviation, lacks documented drug interactions, mechanisms of therapeutic action, or biomarker status, and is not associated with distinct safety concerns or disease roles. There is insufficient data for further structured annotation.

Other names
POTEH-AS1POTEH antisense RNA 1
02

Mechanism of action

Not applicable/none

03

Biological functions

Regulation of gene expression (replication, transcription, translation)Potential involvement in epigenetic modification
04

Disease associations

Other (Antisense RNAs/lncRNAs have roles in various cancers, but no specific disease association for POTEH-AS1 is reported)

Beyond the preview

Go deeper on POTEH antisense RNA 1 (POTEH-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on POTEH antisense RNA 1 (POTEH-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call